2025年全球甲狀腺癌診斷市場報告

預計未來幾年甲狀腺癌診斷市場規模將強勁成長。到 2029 年，這一數字將成長至 40.1 億美元，複合年成長率為 6.2%。預測期內的成長歸因於伴同性診斷需求的增加、患者對個人化醫療的偏好增加、經濟成長和醫療保健支出、醫生教育和培訓以及監管部門的核准和許可。預測期內的全球趨勢包括液態切片、診斷技術全球化、技術進步、研發、人工智慧整合、合作和夥伴關係。

隨著甲狀腺癌病例數量預計會增加，甲狀腺癌診斷市場預計也會擴大。甲狀腺癌是一種影響甲狀腺的疾病，早期發現對於改善治療效果至關重要。診斷工具在甲狀腺癌的早期發現中發揮關鍵作用，滿足了對有效診斷解決方案日益成長的需求。根據美國癌症協會 2023 年 9 月的報告，預計 2023 年將新增 43,720 例甲狀腺癌病例，凸顯了診斷技術進步的必要性。報告也預測，同年將有約 2,120 人死於甲狀腺癌。因此，甲狀腺癌盛行率的上升是推動甲狀腺癌診斷市場發展的關鍵因素。

醫療保健支出的增加將進一步促進甲狀腺癌診斷市場的發展。醫療保健支出包括分配給醫療保健服務的財政資源，是影響診斷市場動態的關鍵因素。醫療保健領域投資的增加促進了先進診斷技術的研究、開發和採用。這項投資將提高創新工具的可近性和可負擔性，以促進甲狀腺癌的早期發現和改善管理。美國醫療保險和醫療補助服務中心發布的《2021-2030年全國醫療保健支出報告》顯示，預計2021年至2030年全國醫療保健支出的年複合成長率將達到5.1%，總額約為6.8兆美元。具體來看醫療保險和醫療補助，預計支出年增率分別為 7.2% 和 5.6%。因此，增加醫療保健支出是推動甲狀腺癌診斷市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球甲狀腺癌診斷PESTEL分析（政治、社會、科技、環境、法律、促進因素、限制因素）
• 最終用途產業分析
• 全球甲狀腺癌診斷市場：成長率分析
• 全球甲狀腺癌診斷市場表現：規模與成長，2019-2024
• 全球甲狀腺癌診斷市場預測：規模與成長，2024-2029 年，2034 年
• 全球甲狀腺癌診斷總體目標市場（TAM）

第6章市場區隔

• 全球甲狀腺癌診斷市場（依技術類型、表現及預測），2019-2024 年、2024-2029 年、2034 年
• 影像檢查
• 血液檢查
• 切片檢查
• 其他測試類型
• 全球甲狀腺癌診斷市場：依疾病類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 乳頭狀癌
• 濾泡性癌
• 其他疾病
• 全球甲狀腺癌診斷市場：按最終用戶、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 醫院檢查室
• 癌症診斷中心
• 研究組織
• 其他最終用戶
• 全球甲狀腺癌診斷市場、影像檢查細分、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• 超音波影像
• 電腦斷層掃描 (CT)
• 磁振造影（MRI）
• 正子斷層掃描（PET）
• 放射性碘掃描
• 全球甲狀腺癌診斷市場，依血液檢測類型細分，績效及預測，2019-2024 年、2024-2029 年、2034 年
• 甲狀腺功能檢查
• 腫瘤標記檢測
• 甲狀腺癌基因檢測
• 全球甲狀腺癌診斷市場、切片檢查細分、類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
• 細針抽吸細胞學檢查（FNA）
• 芯針切片
• 手術切片檢查
• 全球甲狀腺癌診斷市場，按其他檢測類型細分，按類型、實際和預測，2019-2024 年、2024-2029 年、2034 年
• 分子診斷
• 免疫組織化學
• 組織病理學分析

第7章 區域和國家分析

• 全球甲狀腺癌診斷市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
• 全球甲狀腺癌診斷市場：依國家、績效及預測（2019-2024 年、2024-2029 年及 2034 年）

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

• 甲狀腺癌診斷市場：競爭格局
• 甲狀腺癌診斷市場：公司簡介
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • General Electric Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

• Sanofi SA
• Bristol-Myers Squibb Company
• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• GlaxoSmithKline plc
• Eli Lilly and Company
• Toshiba Corporation
• Merck KGaA
• Siemens Healthcare GmbH
• FUJIFILM Holdings Corporation
• Koninklijke Philips NV
• AstraZeneca plc
• Agilent Technologies Inc.
• Hologic Inc.
• Genzyme Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

• 2029年甲狀腺癌診斷市場：提供新機會的國家
• 2029年甲狀腺癌診斷市場：細分市場帶來新機會
• 2029年甲狀腺癌診斷市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手的策略

第36章 附錄

Thyroid cancer diagnostics involves the use of techniques to examine a lump or nodule suspected of being thyroid cancer, aiding in the identification and diagnosis of thyroid cancer. Thyroid cancer is a type of cancer that originates in the thyroid gland when cells undergo uncontrolled growth.

The primary techniques used in thyroid cancer diagnostics include imaging tests, blood tests, biopsies, and other diagnostic procedures. Imaging involves creating visual representations of phenomena such as temperature, sound waves, chemicals, or electrical activity. In the context of thyroid cancer diagnostics, imaging tests are utilized to generate images of the thyroid gland. Different types of thyroid cancer include papillary carcinoma, follicular carcinoma, and others. These diagnostic techniques are employed by various end-users, including hospital laboratories, cancer diagnostic centers, research institutes, and others.

The thyroid cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides thyroid cancer diagnostics market statistics, including thyroid cancer diagnostics industry global market size, regional shares, competitors with a thyroid cancer diagnostics market share, detailed thyroid cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid cancer diagnostics industry. This thyroid cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The thyroid cancer diagnostics market size has grown strongly in recent years. It will grow from $2.99 billion in 2024 to $3.16 billion in 2025 at a compound annual growth rate (CAGR) of 5.7%. The growth in the historic period can be attributed to increasing prevalence of thyroid cancer, aging population, rising awareness and early detection, government initiatives and funding, improved healthcare infrastructure

The thyroid cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to growing demand for companion diagnostics, increasing patient preference for personalized medicine, economic growth and healthcare spending, physician education and training, regulatory approvals and clearances. Major trends in the forecast period include liquid biopsies, globalization of diagnostic technologies, technological advancements, research and development, integration of artificial intelligence, collaborations and partnerships.

The anticipated increase in thyroid cancer cases is set to drive the expansion of the thyroid cancer diagnostic market. Thyroid cancer, a condition affecting the thyroid gland, necessitates early detection for improved treatment outcomes. Diagnostic tools play a crucial role in identifying thyroid cancer at an early stage, meeting the rising demand for effective diagnostic solutions. According to a September 2023 report by the American Cancer Society, an estimated 43,720 new cases of thyroid cancer are expected in 2023, emphasizing the need for diagnostic advancements. The report further projects approximately 2,120 deaths from thyroid cancer in the same year. Consequently, the escalating prevalence of thyroid cancer is a significant driver propelling the thyroid cancer diagnostic market.

The growth of healthcare spending is poised to further boost the thyroid cancer diagnostics market. Healthcare spending, encompassing financial resources allocated to healthcare provision, is a key factor influencing diagnostic market dynamics. The increased investment in healthcare contributes to the research, development, and implementation of advanced diagnostic technologies. This investment enhances accessibility and affordability of innovative tools, fostering early detection and improved management of thyroid cancer. As indicated in the 2021-2030 National Health Expenditure report by the Centers for Medicare & Medicaid Services, the projected annual growth in national health spending is expected to reach 5.1% between 2021 and 2030, totaling nearly $6.8 trillion. With specific focus on Medicare and Medicaid, spending is anticipated to rise at rates of 7.2% and 5.6% annually, respectively. Thus, increased healthcare spending is a key driver fueling the growth of the thyroid cancer diagnostics market.

Major companies in the thyroid cancer diagnostic market are focusing on developing innovative solutions, such as RNA sequencing tests, to improve the accuracy of cancer fusion detection across various solid tumors, including thyroid cancer. RNA sequencing (RNA-Seq) is a high-throughput technique that allows for the analysis of RNA quantity and sequence in a sample, offering insights into gene expression and the overall transcriptome. For example, in March 2024, Foundation Medicine, Inc., a US-based biotechnology company, announced the U.S. launch of FoundationOne RNA, a tissue-based RNA sequencing test designed to detect cancer-related gene fusions across 318 genes. This test provides fusion reporting for all solid tumors and may be especially useful for identifying fusions in cancers such as non-small cell lung cancer (NSCLC), sarcoma, pancreatic cancer, thyroid cancer, cholangiocarcinoma, and bladder cancer.

Major companies in the thyroid cancer diagnostic market are also focusing on the development of innovative products, such as rearranged during transfection (RET) inhibitors. RET inhibitors specifically target and inhibit the activity of the RET protein. CStone Pharmaceuticals gained approval for GAVRETO (pralsetinib) in March 2022. GAVRETO is a selective RET inhibitor sanctioned in China for managing RET-mutant medullary thyroid cancer (MTC) and RET fusion-positive thyroid cancer (TC). This oral targeted therapy addresses the needs of patients with various forms of thyroid cancer, contributing to enhanced diagnostic and treatment options.

In September 2024, The World Tumor Registry (WTR), a US-based non-profit organization focused on the collection and analysis of tumor data, partnered with PathPresenter. This collaboration supports WTR's mission to develop an accessible educational resource for cancer care and research organizations globally, offering a secure and scalable solution to improve cancer diagnostics and education. PathPresenter is a US-based multi-tenant enterprise pathology workflow software platform.

Major companies operating in the thyroid cancer diagnostics market include Pfizer Inc., General Electric, F. Hoffmann-La Roche AG, Bayer AG, Novartis International AG, Sanofi S.A., Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Abbott Laboratories, GlaxoSmithKline plc, Eli Lilly and Company, Toshiba Corporation, Merck KGaA, Siemens Healthcare GmbH, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., AstraZeneca plc, Agilent Technologies Inc., Hologic Inc., Genzyme Corporation, Illumina Inc., BioMerieux SA, Bio-Rad Laboratories Inc., Quest Diagnostics Inc., Qiagen N.V., Cepheid, Veracyte Inc., DiaSorin S.p.A., Myriad Genetics Inc.

North America was the largest region in the thyroid cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the thyroid cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The thyroid cancer diagnostics market includes revenues earned by entities by providing diagnostic tools related detection and diagnosis of thyroid cancer, radioactive tracer, biopsy, blood tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Thyroid Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on thyroid cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for thyroid cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The thyroid cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Technique Type: Imaging Test; Blood Test; Biopsy; Other Test Type
• 2) By Disease Type: Papillary Carcinoma; Follicular Carcinoma; Other Diseases
• 3) By End-User: Hospital Laboratories; Cancer Diagnostic Centers; Research Institutes; Other End-Users
• Subsegments:
• 1) By Imaging Test: Ultrasound Imaging; Computed Tomography (CT) Scans; Magnetic Resonance Imaging (MRI); Positron Emission Tomography (PET) Scans; Radioactive Iodine Scans
• 2) By Blood Test: Thyroid Function Tests; Tumor Marker Tests; Genetic Testing For Thyroid Cancer
• 3) By Biopsy: Fine Needle Aspiration (FNA) Biopsy; Core Needle Biopsy; Surgical Biopsy
• 4) By Other Test Type: Molecular Diagnostics; Immunohistochemistry Tests; Histopathological Analysis
• Companies Mentioned: Pfizer Inc.; General Electric; F. Hoffmann-La Roche AG; Bayer AG; Novartis International AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Thyroid Cancer Diagnostics Market Characteristics

3. Thyroid Cancer Diagnostics Market Trends And Strategies

4. Thyroid Cancer Diagnostics Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid And Recovery on the Market

5. Global Thyroid Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Thyroid Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Thyroid Cancer Diagnostics Market Growth Rate Analysis
• 5.4. Global Thyroid Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Thyroid Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Thyroid Cancer Diagnostics Total Addressable Market (TAM)

6. Thyroid Cancer Diagnostics Market Segmentation

• 6.1. Global Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Test
• Blood Test
• Biopsy
• Other Test Type
• 6.2. Global Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Papillary Carcinoma
• Follicular Carcinoma
• Other Diseases
• 6.3. Global Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospital Laboratories
• Cancer Diagnostic Centers
• Research Institutes
• Other End-Users
• 6.4. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Imaging Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ultrasound Imaging
• Computed Tomography (CT) Scans
• Magnetic Resonance Imaging (MRI)
• Positron Emission Tomography (PET) Scans
• Radioactive Iodine Scans
• 6.5. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Blood Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Thyroid Function Tests
• Tumor Marker Tests
• Genetic Testing For Thyroid Cancer
• 6.6. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fine Needle Aspiration (FNA) Biopsy
• Core Needle Biopsy
• Surgical Biopsy
• 6.7. Global Thyroid Cancer Diagnostics Market, Sub-Segmentation Of Other Test Type, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Molecular Diagnostics
• Immunohistochemistry Tests
• Histopathological Analysis

7. Thyroid Cancer Diagnostics Market Regional And Country Analysis

• 7.1. Global Thyroid Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Thyroid Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Thyroid Cancer Diagnostics Market

• 8.1. Asia-Pacific Thyroid Cancer Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Thyroid Cancer Diagnostics Market

• 9.1. China Thyroid Cancer Diagnostics Market Overview
• 9.2. China Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Thyroid Cancer Diagnostics Market

• 10.1. India Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Thyroid Cancer Diagnostics Market

• 11.1. Japan Thyroid Cancer Diagnostics Market Overview
• 11.2. Japan Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Thyroid Cancer Diagnostics Market

• 12.1. Australia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Thyroid Cancer Diagnostics Market

• 13.1. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Thyroid Cancer Diagnostics Market

• 14.1. South Korea Thyroid Cancer Diagnostics Market Overview
• 14.2. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Thyroid Cancer Diagnostics Market

• 15.1. Western Europe Thyroid Cancer Diagnostics Market Overview
• 15.2. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Thyroid Cancer Diagnostics Market

• 16.1. UK Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Thyroid Cancer Diagnostics Market

• 17.1. Germany Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Thyroid Cancer Diagnostics Market

• 18.1. France Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Thyroid Cancer Diagnostics Market

• 19.1. Italy Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Thyroid Cancer Diagnostics Market

• 20.1. Spain Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Thyroid Cancer Diagnostics Market

• 21.1. Eastern Europe Thyroid Cancer Diagnostics Market Overview
• 21.2. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Thyroid Cancer Diagnostics Market

• 22.1. Russia Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Thyroid Cancer Diagnostics Market

• 23.1. North America Thyroid Cancer Diagnostics Market Overview
• 23.2. North America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Thyroid Cancer Diagnostics Market

• 24.1. USA Thyroid Cancer Diagnostics Market Overview
• 24.2. USA Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Thyroid Cancer Diagnostics Market

• 25.1. Canada Thyroid Cancer Diagnostics Market Overview
• 25.2. Canada Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Thyroid Cancer Diagnostics Market

• 26.1. South America Thyroid Cancer Diagnostics Market Overview
• 26.2. South America Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Thyroid Cancer Diagnostics Market

• 27.1. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Thyroid Cancer Diagnostics Market

• 28.1. Middle East Thyroid Cancer Diagnostics Market Overview
• 28.2. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Thyroid Cancer Diagnostics Market

• 29.1. Africa Thyroid Cancer Diagnostics Market Overview
• 29.2. Africa Thyroid Cancer Diagnostics Market, Segmentation By Technique Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Thyroid Cancer Diagnostics Market, Segmentation By Disease Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Thyroid Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Thyroid Cancer Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Thyroid Cancer Diagnostics Market Competitive Landscape
• 30.2. Thyroid Cancer Diagnostics Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. General Electric Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis

31. Thyroid Cancer Diagnostics Market Other Major And Innovative Companies

• 31.1. Sanofi S.A.
• 31.2. Bristol-Myers Squibb Company
• 31.3. Thermo Fisher Scientific Inc.
• 31.4. Abbott Laboratories
• 31.5. GlaxoSmithKline plc
• 31.6. Eli Lilly and Company
• 31.7. Toshiba Corporation
• 31.8. Merck KGaA
• 31.9. Siemens Healthcare GmbH
• 31.10. FUJIFILM Holdings Corporation
• 31.11. Koninklijke Philips N.V.
• 31.12. AstraZeneca plc
• 31.13. Agilent Technologies Inc.
• 31.14. Hologic Inc.
• 31.15. Genzyme Corporation

32. Global Thyroid Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Thyroid Cancer Diagnostics Market

34. Recent Developments In The Thyroid Cancer Diagnostics Market

35. Thyroid Cancer Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Thyroid Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Thyroid Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Thyroid Cancer Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer